News from shield therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 06, 2014, 09:00 ET

Blue Cross Blue Shield Association and Prime Therapeutics Study Demonstrates Health Benefits and Cost Savings of Pharmacy Benefit Integration within Insurance Plans

Blue Cross Blue Shield Association (BCBSA) and Prime Therapeutics LLC (Prime) today released a study demonstrating clear health benefits and cost...

Feb 04, 2014, 02:00 ET

Shield Therapeutics Announces Acceptance of ST10 Abstract for Presentation at ECCO Congress 2014

Shield Therapeutics (Shield), an independent specialty pharmaceutical company, today announces the acceptance of the first peer-reviewed abstract...

Jan 07, 2014, 02:00 ET

Shield Therapeutics' ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease

~ ST10 strongly demonstrates potential to be (1) the only effective oral treatment for ferrous intolerant IDA patients and (2) an effective...

Dec 16, 2013, 02:00 ET

FDA Grants Approval of IND to Commence a Phase 3 Pivotal Study for ST10 for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today...

Nov 12, 2013, 02:00 ET

Shield Therapeutics Files Investigational New Drug Application for ST10 for the Treatment of Iron Deficiency in Chronic Kidney Disease

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today...

Oct 23, 2013, 04:00 ET

Shield Therapeutics to Attend BIO-Europe® 2013

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today...

Jun 24, 2013, 02:00 ET

Shield Therapeutics Completes Recruitment to Pivotal Phase 3 Programme for Treatment of Iron Deficiency

Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of...

Oct 12, 2011, 02:00 ET

Shield Therapeutics Initiates AEGIS 1 and AEGIS 2 Phase 3 Studies of ST10

- Two pivotal trials initiated for treatment of iron deficiency anaemia associated with ulcerative colitis and Crohn's disease - Shield...

Jun 01, 2011, 03:00 ET

Shield Therapeutics Raises EUR8.2 Million From Inventages Venture Capital via Series A Institutional Round

- New Investment to Further Fund the Phase III Clinical Programme of ST10-021 in Iron Deficiency Anaemia Shield Therapeutics (Shield), the...

Jan 07, 2011, 07:00 ET

Shield Therapeutics to Present at the Biotech Showcase 2011

Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage...

Nov 01, 2010, 03:00 ET

Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021

- AOP Orphan to Make Strategic EUR3m Investment in Shield Holdings Shield Holdings AG (Shield), the independent specialty pharmaceutical company...